Bilcare Research: Investment in European production of Aclar® laminates

Bilcare Research, a leading manufacturer of mono and multi-layer barrier films for the pharmaceutical industry, announced the production of Aclar® multilayer films at its Bötzingen facility in Germany. The base film production as well as the lamination is done at the ISO 15378 certified site.

The new investment marks a significant milestone in offering integrated solutions and supply chain advantages for the global pharmaceutical industry. It shall allow Bilcare to offer best in class delivery of Aclar® laminates for stability packaging, line trial samples as well as full commercial volumes.

Bilcare's range of Aclar® laminates shall provide the highest moisture barrier of any films of its type and are crystal clear, biochemically inert, chemical-resistant, non-flammable and plasticizer- as well as stabilizer-free.

"This investment in our new laminating line is the latest component of our continued growth strategy to meet the needs of the rapidly evolving business models of the global pharmaceutical industry. We see increased demand across our entire range of Bilcare Aclar® laminates, from both innovator and generic pharmaceutical companies”, commented Thorsten Kühn, CEO of Bilcare Research AG, Switzerland.